Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds.

Huang, Jinghuan; Yu, Muyu; Yin, Wenjing; Liang, Bo; Li, Ang; Li, Jingfeng; Li, Xiaolin; Zhao, Shichang; Liu, Fang

Huang, Jinghuan; Yu, Muyu; Yin, Wenjing; Liang, Bo; Li, Ang; Li, Jingfeng; Li, Xiaolin; Zhao, Shichang; Liu, Fang.

Afiliação

Huang J; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.
Yu M; Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.
Yin W; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.
Liang B; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.
Li A; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.
Li J; Department of Orthopedics, Zhongnan Hospital of Wuhan University, China.
Li X; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.
Zhao S; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.
Liu F; Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China.

Bioact Mater ; 6(9): 2841-2853, 2021 Sep.

Article em En | MEDLINE | ID: mdl-33718666

Palavras-chave

Diabetes chronic wounds; Engineered exosomes; Precision therapy; RNAi therapy; miR-31-5p

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioact Mater Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google